secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2026-06-15T20:40:42+00:00
Accession:  0001104659-26-074090
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coherus Oncology dismisses EY as auditor, appoints PwC effective June 12, 2026
------------------------------------------------------------------------------

- Dismissed Ernst & Young as auditor effective June 12, 2026; no adverse opinions or disagreements in prior periods.
- Audit committee selected PricewaterhouseCoopers as new auditor for FY 2026, subject to standard client acceptance.
- A material weakness in internal control over inventory reconciliations reported for FY 2024 was remediated by FY 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000110465926074090/0001104659-26-074090-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000110465926074090/chrs-20260612x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-074090

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer